In summary, while statins are histone acetylation inhibitors with demonstrated efficacy in treating atherosclerosis and CAD, other HDAC and HAT inhibitors have shown improvement in the progression of atherosclerosis, CAD, and HF, but these have not yet been applied clinically for CVD treatment. The gene discussed is TMPRSS11D; the disease is atherosclerosis.